AFT first-half net profit fell 66%, even as sales lifted 18%

AFT first-half net profit fell 66%, even as sales lifted 18%
Chair David Flacks said it's appropriate to invest more to spur growth. (Image: Supplied)
Jenny Ruth
AFT Pharmaceuticals' first-half net profit fell by 66% despite a more than 18% jump in revenue and a 30% growth in product sales and royalties, and it downgraded guidance for the full year.AFT also downgraded guidance provided in May and now expected operating profit of between $18 million and $23m for the full year ending March 2023, down from between $27m to $32m, saying that reflected growth investments and deferred license income due to the delay in Maxigesic IV getting US registration.However, the company is still expecting to pay a ma...

More Markets

US tariff risk less than expected for FPH, Jarden says
Economy

US tariff risk less than expected for FPH, Jarden says

Jarden says tariff-related impacts on earnings would be "nominal" by 2030.

Jarden says Skellerup 'most exposed' to Trump's tariffs
Markets

Jarden says Skellerup 'most exposed' to Trump's tariffs

US President Donald Trump's sweeping global tariffs, announced on Thursday, are expected to have devastating consequences not only in the US but also in New Zealand.In a note on Friday morning, Jarden analysts Guy Hooper and Nick Yeo predicted that NZX-listed Skellerup looks...

Wall Street reels as Trump’s plan sinks markets
Markets

Wall Street reels as Trump’s plan sinks markets

The president’s sweeping tariffs proved far more severe than investors predicted.

Iron sand project could deliver $265m GDP boost: NZIER
Economy

Iron sand project could deliver $265m GDP boost: NZIER

Iron sands mining in Taranaki could create 1365 jobs, NZIER report says.